R&D expenses of ¥35 million for the six-month period ended in the second quarter
First written in FY2017-Q2. 3 of 19 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Total R&D expenses were ¥99 million. The Parking Systems Business Department continued developing next-generation bicycle-parking services. Development progressed on the “Bicycle IT Business (provisional name),” the top idea of fiscal 2023, and on 24 March 2026 the company released the new NCD brand’s bicycle-only drive recorder, “Jitereko.”」
R&D expenses increased from ¥41 million in the previous fiscal year to ¥99 million. In addition to continued development of next-generation bicycle-parking services, the release of “Jitereko” indicated progress toward commercialization. - FY2026-H1Updated interim research and development expensesAnnual report
「Total R&D expenses for the six months ended were ¥63 million. There were no material changes in the status of the group’s R&D activities during the six months ended.」
Cumulative R&D expenses for the interim period were ¥63 million. It was stated that there had been no material changes in the status of R&D activities. - FY2025AdvancedAnnual report
「Total R&D expenses were ¥41 million. The Parking Systems Business Department began development aimed at introducing next-generation bicycle-parking services.」
R&D activity expanded again, with ¥41 million recorded as R&D expenses. The company newly disclosed that it had begun developing next-generation bicycle-parking services. For other new business creation initiatives, it had also begun developing the “Bicycle IT Business (provisional name)” through the business idea solicitation program “co-do project.” - FY2025-H1Updated interim research and development expensesAnnual report
「Total R&D expenses for the current interim consolidated accounting period were ¥3 million.」
Cumulative R&D expenses for the interim period were ¥3 million. - FY2021Updated annual R&D expenses to ¥0.3 millionAnnual report
「Total R&D expenses included in selling, general and administrative expenses were as follows: Fiscal year 336 ¥ thousand」
Annual R&D expenses were ¥336 thousand, down from ¥5.048 million in the previous fiscal year. Regarding R&D activities, the company stated that there were no matters requiring special mention. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the six months ended were ¥0 million. There were no material changes in the status of the group’s R&D activities during the six months ended.」
R&D expenses remained at ¥0 million for the six months ended following the first quarter, and it was stated that there had been no material changes in the status of R&D activities. - FY2021-Q1Updated R&D expenses for the first quarter to ¥0 millionAnnual report
「Total R&D expenses for the three months ended were ¥0 million.」
Cumulative R&D expenses for the three months ended were disclosed at ¥0 million. It was stated that there had been no material changes in the status of R&D activities. - FY2020Updated annual R&D expenses to ¥5 millionAnnual report
「Total R&D expenses for the fiscal year were ¥5 million.」
Development of DenDen2 continued, and full-year cumulative R&D expenses were updated to ¥5 million. - FY2020-Q3Updated cumulative R&D expenses for the nine months ended to ¥4 millionAnnual report
「The company began developing the upgraded new product “DenDen2” from the three months ended. Total R&D expenses for the nine months ended were ¥4 million.」
The initiation of development of DenDen2 continued to be disclosed, and cumulative R&D expenses were updated from ¥3 million for the six months ended to ¥4 million. - FY2020-Q2Updated cumulative R&D expenses for the six months ended to ¥3 millionAnnual report
「The company had been selling the bone-conduction headphones “DenDen” since December 2017. As demand increased for a product that could serve as an alternative to a hearing aid by combining a sound collector with bone-conduction headphones, and other companies began selling products with the same specifications, the company began developing the upgraded new product “DenDen2” from the three months ended. Total R&D expenses for the six months ended were ¥3 million.」
The initiation of development of DenDen2 continued to be disclosed, and cumulative R&D expenses were updated from ¥2 million for the first quarter to ¥3 million. - FY2020-Q1AdvancedAnnual report
「The company had been selling the bone-conduction headphones “DenDen” since December 2017. As demand increased for a product that could serve as an alternative to a hearing aid by combining a sound collector with bone-conduction headphones, and other companies began selling products with the same specifications, the company began developing the upgraded new product “DenDen2” from the three months ended. Total R&D expenses for the three months ended were ¥2 million.」
The company’s initiation of development of DenDen2 was disclosed, whereas no R&D activities had been described for the previous full fiscal year, and R&D expenses of ¥2 million for the first quarter were disclosed. - FY2019Updated the description of full-year R&D activitiesAnnual report
「5 [Research and Development Activities] Not applicable.」
Unlike the previous fiscal year, when R&D expenses of ¥15 million were disclosed, this filing contains no description of R&D activities. - FY2018Updated annual R&D expenses to ¥15 millionAnnual report
「R&D expenses for the fiscal year were ¥15 million.」
Full-year disclosed R&D expenses were updated to ¥15 million. The IRT Promotion Department is working to improve the performance of high-speed data-processing devices. - FY2018-Q3Updated cumulative R&D expenses for the nine months ended to ¥11 millionAnnual report
「Total R&D expenses for the nine months ended were ¥11 million. There were no material changes in the status of the group’s R&D activities during the nine months ended.」
The disclosed cumulative R&D expenses were updated from ¥8 million for the six months ended to ¥11 million. It was stated that there had been no material changes in the status of R&D activities. - FY2018-Q2Updated cumulative R&D expenses for the six months ended to ¥8 millionAnnual report
「Total R&D expenses for the six months ended were ¥8 million. There were no material changes in the status of the group’s R&D activities during the six months ended.」
The disclosed cumulative R&D expenses were updated from ¥3 million for the three months ended to ¥8 million. It was stated that there had been no material changes in the status of R&D activities. - FY2018-Q1Updated cumulative R&D expenses for the first quarter to ¥3 millionAnnual report
「Total R&D expenses for the three months ended were ¥3 million. There were no material changes in the status of the group’s R&D activities during the three months ended.」
The disclosed cumulative R&D expenses were updated from ¥49 million for the full fiscal year to ¥3 million for the three months ended. It was stated that there had been no material changes in the status of R&D activities. - FY2017Updated annual R&D expenses to ¥49 millionAnnual report
「R&D expenses for the fiscal year were ¥49 million.」
R&D expenses were updated from ¥44 million for the nine months ended to ¥49 million for the full fiscal year. The company described efforts to improve the performance of high-speed data-processing devices and collaboration with memory-based computing technology, AI and other technologies. - FY2017-Q3Updated cumulative R&D expenses to ¥44 millionAnnual report
「Total R&D expenses for the nine months ended were ¥44 million. There were no material changes in the status of the group’s R&D activities during the nine months ended.」
The disclosed cumulative R&D expenses were updated from ¥35 million for the six months ended to ¥44 million, while it was stated that there had been no material changes in the status of R&D activities. - FY2017-Q2First statedAnnual report
「Total R&D expenses for the six months ended were ¥35 million. There were no material changes in the status of the group’s R&D activities during the six months ended.」
R&D expenses for the six months ended were disclosed at ¥35 million, and it was stated that there had been no material changes in the status of R&D activities.